Anti-TNF Agents in Behçet's Disease Treatment

Semih Tatlıcan

Issue: Volume 24 - Issue 1 - June 2009
1273 3101

New Treatment Strategies in the Treatment of Juvenile Idiopathic Arthritis

İbrahim GÖKÇE, Erkan DEMİRKAYA

DOI: 10.5606/tjr.2011.012

Issue: Volume 26 - Issue 1 - January 2011
18192 7729

The Reported Adverse Effects Related to Biological Agents Used for the Treatment of Rheumatic Diseases in Turkey

Erkan KILIÇ, Gamze KILIÇ, Özgür AKGÜL, Gürkan AKGÖL, Salih ÖZGÖÇMEN

DOI: 10.5606/tjr.2013.3052

Issue: Volume 28 - Issue 3 - September 2013
13808 5440

The Off-Label Use of Rituximab for the Management of Inflammatory Disorders: American University of Beirut Medical Center Experience

Dana HARB, Hiba MOUKADEM, Rabih NAYFE, Ali MEHDI, Abdel Fattah MASRI, Ziad SALEM, Ali TAHER, Imad UTHMAN

DOI: 10.5606/ArchRheumatol.2014.3855

Issue: Volume 29 - Issue 3 - September 2014
10817 4896

Immunoglobulin G4-Related Disease Presented as Recurrent Otitis Media and Mixed Hearing Loss Treated With Cyclophosphamide and Rituximab: A Case Report

Shao SAN, Chia-der LIN, Sheng-ta TSAI, Chao-chun LIN, Po-chang WU

DOI: 10.5606/ArchRheumatol.2019.7178

Issue: Volume 34 - Issue 2 - June 2019
1787 2189

Pre-Pulseless Takayasu Arteritis in a Child Represented With Prolonged Fever of Unknown Origin and Successful Management With Concomitant Mycophenolate Mofetil and Infliximab

Rabia Miray KIŞLA EKİNCİ, Sibel BALCI, Ferhat Can PİŞKİN, Celal VARAN, Sevcan ERDEM, Mustafa YILMAZ

DOI: 10.46497/ArchRheumatol.2020.7599

Issue: Volume 35 - Issue 2 - June 2020
1661 1579

Efficacy of Rituximab for Refractory Pyoderma Gangrenosum-Like Ulcers in Granulomatosis With Polyangiitis Associated to Antiphospholipid Antibodies

Julia RIERA, Jorge MUSURUANA, Cecilia COSTA, Javier CAVALLASCA

DOI: 10.46497/ArchRheumatol.2020.7498

Issue: Volume 35 - Issue 3 - September 2020
1586 2232

Infliximab therapy provides beneficial effects for choroidal thickness increase in patients with active ankylosing spondylitis: A possible mechanism mediating the suppressing of uveitis attacks

Murat KARKUCAK, Mehmet KOLA, Ahmet KALKIŞIM, Erhan ÇAPKIN, Ahmet AYAR, Adem TÜRK

DOI: 10.46497/ArchRheumatol.2021.7806

Issue: Volume 36 - Issue 1 - March 2021
1522 1938

Analysis of treatment outcomes in patients with antineutrophil cytoplasmic antibody-associated vasculitis on rituximab therapy

Tsvetelina Yoneva, Yana Zdravkova, Georgi Kotov, Ekaterina Ivanova Todorova, Georgi Vasilev, Rasho Rashkov, Ivan Sheytanov

DOI: 10.46497/ArchRheumatol.2023.9556

Issue: Volume 38 - Issue 3 - September 2023
635 571

Rituximab for rheumatoid arthritis-related interstitial lung disease: A systematic review and meta-analysis

Tarun Krishna Boppana, Saurabh Mittal, Karan Madan, Anant Mohan, Vijay Hadda, Randeep Guleria

DOI: 10.46497/ArchRheumatol.2024.10199

Issue: Volume 39 - Issue 2 - June 2024
26 47